Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy

被引:50
作者
Szalay, ZA
Civelek, A
Hohe, S
Brunner-LaRocca, HP
Klövekorn, WP
Knez, I
Vogt, PR
Bauer, EP
机构
[1] Kerckhoff Clin Fdn, D-61231 Bad Nauheim, Germany
[2] Univ Zurich Hosp, Dept Cardiol, CH-8001 Zurich, Switzerland
[3] Univ Hosp, Dept Cardiovasc Surg, D-35385 Giessen, Germany
关键词
mitral valve disease; ischemic mitral regurgitation; heart failure cardiomyopathy;
D O I
10.1016/S1010-7940(02)00864-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Mitral regurgitation is a frequent finding in patients with end-stage cardiomyopathy predicting poor survival. Conventional treatment consists medical treatment or cardiac transplantation. However, despite severely decreased left ventricular function, mitral annuloplasty may improve survival and reduce the need for allografts. Methods: From January 1996 to July 2002, 121 patients with severe end-stage dilated (DCM) or ischemic cardiomyopathy (ICM), mitral regurgitation greater than or equal to2, and left ventricular ejection fraction less than or equal to30% underwent mitral valve annuloplasty using a flexible posterior ring. DCM was diagnosed in 30 patients (25%), whereas ICM was found in 91 patients (75%). Concomitant tricuspid valve repair was performed in 14 (46.6%) patients in the DCM, and in 11 (12%) in the ICM group (P = 0.0001), coronary artery bypass grafting in three (10%) in the DCM, and in 78 patients (86%) in the ICM group (P < 0.00001). The mean follow-up time was 567 +/- 74 days in the DCM and 793 +/- 63 days in the ICM group (ns). Results: Early mortality was 6.6% (8/121), and was equal for both groups. Improvement in NYHA class (DCM 3.3 + 0.1-1.8 +/- 0.16; ICM from 3.2 + 0.04 to 1.7 +/- 0.07) were equal between groups after I year. Seventeen (15%) late deaths occurred during the follow-up period. There was no difference in the 2-year actuarial survival between groups (DCM/ICM 0.93/0.85). Risk factors for mitral reconstruction failure, defined as regurgitation : 2 after I year, were preoperative NYHA IV in the DCM group (P = 0.03), a preoperative posterior infarction (P = 0.025), decreased left ventricular function (P = 0.043), larger ring size (P = 0.026) and preoperative renal failure (P = 0.05) in the ICM group. Risk factors for death were larger ring size (P = 0.02) and an increased LVEDD (P = 0.027) in the DCM group and the postoperative use of IABP (P = 0.002), renal failure (P = 0.001), and a larger preoperative LVESD (P = 0.035) in the ICM group. Conclusion: Mitral reconstruction with a posterior annuloplasty using a flexible ring is effective in patients with severely depressed left ventricle function and has an acceptable operative mortality. Mid-term results are superior to medical treatment alone and comparable to cardiac transplantation. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 22 条
[1]   CLINICAL AND HEMODYNAMIC PREDICTORS OF SURVIVAL IN PATIENTS AGED LESS-THAN-65 YEARS WITH SEVERE CONGESTIVE-HEART-FAILURE SECONDARY TO ISCHEMIC OR NONISCHEMIC DILATED CARDIOMYOPATHY [J].
ANGUITA, M ;
ARIZON, JM ;
BUENO, G ;
LATRE, JM ;
SANCHO, M ;
TORRES, F ;
GIMENEZ, D ;
CONCHA, M ;
VALLES, F .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) :413-417
[2]   DILATED CARDIOMYOPATHY WITH MITRAL REGURGITATION - DECREASED SURVIVAL DESPITE A LOW-FREQUENCY OF LEFT-VENTRICULAR THROMBUS [J].
BLONDHEIM, DS ;
JACOBS, LE ;
KOTLER, MN ;
COSTACURTA, GA ;
PARRY, WR .
AMERICAN HEART JOURNAL, 1991, 122 (03) :763-771
[3]   EARLY OUTCOME OF MITRAL-VALVE RECONSTRUCTION IN PATIENTS WITH END-STAGE CARDIOMYOPATHY [J].
BOLLING, SF ;
DEEB, GM ;
BRUNSTING, LA ;
BACH, DS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (04) :676-683
[4]   Intermediate-term outcome of mitral reconstruction in cardiomyopathy [J].
Bolling, SF ;
Pagani, FD ;
Deeb, GM ;
Bach, DS .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (02) :381-386
[5]   Mitral valve procedure in dilated cardiomyopathy:: Repair or replacement? [J].
Calafiore, AM ;
Gallina, S ;
Di Mauro, M ;
Gaeta, F ;
Iacò, AL ;
D'Alessandro, S ;
Mazzei, V ;
Di Giammarco, G .
ANNALS OF THORACIC SURGERY, 2001, 71 (04) :1146-1152
[6]  
CARPENTIER A, 1971, J THORAC CARDIOV SUR, V61, P1
[7]  
Chen FY, 1998, CIRCULATION, V98, pII124
[8]  
CHRISTAKIS GT, 1998, CIRCULATION S, V78, pI25
[9]   THE EFFECT OF PATHOPHYSIOLOGY ON THE SURGICAL-TREATMENT OF ISCHEMIC MITRAL REGURGITATION - OPERATIVE AND LATE RISKS OF REPAIR VERSUS REPLACEMENT [J].
COHN, LH ;
RIZZO, RJ ;
ADAMS, DH ;
COUPER, GS ;
SULLIVAN, TE ;
COLLINS, JJ ;
ARANKI, SF .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1995, 9 (10) :568-574
[10]   Is repair preferable to replacement for ischemic mitral regurgitation? [J].
Gillinov, AM ;
Wierup, PN ;
Blackstone, EH ;
Bishay, ES ;
Cosgrove, DM ;
White, J ;
Lytle, BW ;
McCarthy, PM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06) :1125-+